FIELD: chemistry.
SUBSTANCE: invention relates to a hexapeptide of formula Thr-Gly-Glu-Asn-His-Arg-NH2, having neuroprotective and nootropic activity. Disclosed novel pharmaceutical composition based on a peptide, which is highly effective in low doses and is used as nasal drops.
EFFECT: high efficiency in preventing and treating neurodegenerative and cerebrovascular diseases.
2 cl, 3 dwg, 6 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| ANTIANXIETY DRUGS AND PHARMACEUTICAL COMPOSITIONS WITH ANXIOLYTIC EFFECTS | 2014 |
|
RU2580311C1 |
| PEPTIDE WITH NEUROPROTECTIVE ACTIVITY ON MODEL OF MFTP-INDUCED PARKINSONISM AND A PHARMACEUTICAL COMPOSITION ON ITS BASIS | 2017 |
|
RU2662429C1 |
| PHARMACEUTICAL COMPOSITION FOR TREATING BURN SKIN LESIONS | 2018 |
|
RU2704621C1 |
| TREATMENT OF NEUROLOGICAL DISEASES | 2017 |
|
RU2755997C2 |
| PREVENTION AND TREATMENT OF CEREBRAL AMYLOID ANGIOPATHY | 2008 |
|
RU2523894C2 |
| PEPTIDE, PHARMACEUTICAL COMPOSITION (VERSIONS) AND MEDICATION | 2007 |
|
RU2492183C2 |
| PEPTIDE, POSSESSING ANTI-TUMOR AND ANTI-METASTATIC ACTIVITY, AND FINISHED DOSAGE FORM BASED THEREON | 2018 |
|
RU2682039C1 |
| AGENT REDUCING RELATIVE CONTENT OF LOW-DIFFERENTIATED CELLS AND INCREASING RELATIVE CONTENT OF HIGH-DIFFERENTIATED CELLS IN INVASIVE MAMMARY GLAND CARCINOMA OF NON-SPECIFIC TYPE | 2022 |
|
RU2786528C1 |
| PEPTIDE ELICITING ANTITUMOR, PROTECTIVE AND NORMALIZING ACTIVITY AND PHARMACEUTICAL COMPOSITION | 1999 |
|
RU2213747C2 |
| PEPTIDE HAVING LYNX1 PROTEIN ACTIVITY (EMBODIMENTS), PHARMACEUTICAL COMPOSITION FOR TREATING ANXIETY DISORDERS AND DEPRESSION OR CORRECTION OF COGNITIVE DISORDERS IN NEURODEGENERATIVE DISEASES, CONTAINING SAID PEPTIDE, AND METHOD OF TREATING AND CORRECTING SAID DISORDERS | 2020 |
|
RU2734649C1 |
